Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4000 participants
OBSERVATIONAL
2005-03-31
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* examine the aspects of safety and effectiveness of bivalirudin
* gain experience regarding the characteristics of patients in bivalirudin treatment
* evaluate the handling of bivalirudin and its practicality
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI
NCT01848106
Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
NCT00262054
RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)
NCT00317343
Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI
NCT00093184
Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
NCT01555658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bivalirudin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nycomed
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clinical Trial Operations
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nycomed Clinical Trial Operations
Role: STUDY_CHAIR
Headquaters
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nycomed
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BI-001-IM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.